Cargando…
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria
BACKGROUND: Malaria is a leading cause of mortality, particularly in sub-Saharan African children. Prompt and efficacious treatment is important as patients may progress within a few hours to severe and possibly fatal disease. Chlorproguanil-dapsone-artesunate (CDA) was a promising artemisinin-based...
Autores principales: | Van Malderen, Carine, Van Geertruyden, Jean-Pierre, Machevo, Sonia, González, Raquel, Bassat, Quique, Talisuna, Ambrose, Yeka, Adoke, Nabasumba, Carolyn, Piola, Patrice, Daniel, Atwine, Turyakira, Eleanor, Forret, Pascale, Van Overmeir, Chantal, Van Loen, Harry, Robert, Annie, D’ Alessandro, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393623/ https://www.ncbi.nlm.nih.gov/pubmed/22546009 http://dx.doi.org/10.1186/1475-2875-11-139 |
Ejemplares similares
-
An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
por: Owusu-Agyei, Seth, et al.
Publicado: (2008) -
High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency
por: Fanello, Caterina I., et al.
Publicado: (2008) -
Open-Label Comparative Clinical Study of Chlorproguanil−Dapsone Fixed Dose Combination (Lapdap™) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria
por: Wootton, Daniel G., et al.
Publicado: (2008) -
Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
por: Premji, Zul, et al.
Publicado: (2009) -
Dapsone: Haemolysis leading to anaemia: case report
Publicado: (2021)